MedTrace Logo

Mechanomyography for Predictor of Prognosis in CuTS and PND Patients

NCT04322448 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 23

Last updated 2025-09-09

No results posted yet for this study

Summary

The study will be a non-blinded two cohort design consisting only of symptomatic patients with CuTS or compressive peroneal neuropathy or in need of peroneal nerve decompression. The first cohort will be - patients with CuTS. Evaluation of each CuTS patient will include assessment by the treating surgeon and a certified hand therapist. Patients who have clinical examination and history consistent with a diagnosis of CuTS based on subjective and functional assessment outlined below will be consented to this study. The second cohort will be patients in need PND for compressive neuropathy of peroneal nerve. PND patients will be evaluated by clinical exam and have imaging with high resolution ultrasound or MRI negative for mass lesion.

Conditions

  • Cubital Tunnel Syndrome
  • Peroneal Nerve Entrapment

Interventions

DEVICE

Mechanomyography (MMG)

MMG, as described in the cohort descriptions, to be used during surgery to see if they are predictive of patient outcomes.

Sponsors & Collaborators

  • Mayo Clinic

    collaborator OTHER

  • Washington University School of Medicine

    lead OTHER

Principal Investigators

  • Wilson Z Ray, MD · Washington University School of Medicine

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-08-03
Primary Completion
2022-07-05
Completion
2023-02-17
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04322448 on ClinicalTrials.gov